In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals
Yıl: 2021 Cilt: 18 Sayı: 2 Sayfa Aralığı: 111 - 115 Metin Dili: İngilizce DOI: 10.4274/tjps.galenos.2020.67366 İndeks Tarihi: 13-01-2022
In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals
Öz: Objectives: The current study focused on the evaluation of the cytotoxic effect and permeability of ziprasidone hydrochloride monohydrate (ZHM) nanocrystals on Caco-2 cells. Materials and Methods: ZHM nanocrystals were prepared by the microfluidization method in the presence of polyvinylpyrrolidone as a stabilizer. Particle size (PS), particle size distribution (PDI), and zeta potential (ZP) values were measured in characterization studies. In vitro cytotoxic effects of ZHM nanocrystals were investigated using the 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test. Caco-2 transport studies were conducted with formulations of ZHM coarse powder and nanocrystals. Results: Nanocrystals were obtained with 400-600 nm PS, 0.1-0.4 PDI, and >20 mV ZP values. The cell viability remained 100% for all sample groups. The permeability value of ZHM nanocrystals through Caco-2 cells increased 2.3-fold in comparison with ZHM coarse powder. Cumulative drug transport also increased at the end of the sampling period. Conclusion: Nanocrystal technology helps to increase the permeability of drug particles by increasing the saturation solubility.
Anahtar Kelime: Ziprasidon Hidroklorür Monohidrat Nanokristallerinin Caco-2 Hücre İn Vitro Geçirgenlik Çalışmaları
Öz: Amaç: Bu çalışma, ziprasidone hidroklorür monohidrat (ZHM) nanokristallerinin Caco-2 hücreleri üzerindeki sitotoksik etkisini ve geçirgenliğini değerlendirmeye odaklanmıştır. Gereç ve Yöntemler: ZHM nanokristalleri, stabilizan olan polivinilpirolidon varlığında mikrofluidizasyon yöntemi ile hazırlanmıştır. Partikül büyüklüğü (PB), partikül büyüklüğü dağılımı (PBD) ve zeta potansiyel (ZP) değerleri karakterizasyon çalışmalarıyla ölçülmüştür. ZHM nanokristallerinin in vitro sitotoksik etkisi 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide testi ile belirlenmiştir. Caco-2 hücreleri taşınma çalışmaları, ZHM kaba tozu ve nanokristal formülasyonları ile gerçekleştirilmiştir. Bulgular: ZHM nanokristalleri 400-600 nm PB, 0,1-0,4 PBD ve >20 mV ZP değerleri ile elde edilmiştir. Tüm çalışma gruplarında hücre canlılığı %100 kalmıştır. Caco-2 hücrelerinden geçiş çalışmalarında, ZHM nanokristalleri, permeabilite değerini ZHM kaba tozuna kıyasla 2,3 kat artırmıştır. Aynı zamanda kümülatif ilaç taşınımı örnek alma süresinin sonunda yükselmiştir. Sonuç: Nanokristal teknolojisi doygunluk çözünürlüğünü artırmasına bağlı olarak permeabiliteyi artırmada yarar sağlayabilir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol. 2008;36:43-48.
- Wu W, Nancollas GH. A new understanding of the relationship between solubility and particle size. J Solution Chem. 1998;27:521-531.
- Scholz P, Arntjen A, Müller RH, Keck CM. ARTcrystal® process for industrial nanocrystal production - Optimization of the ART MICCRA premilling step. Int J Pharm. 2014;465:388-395.
- Zhai X, Lademann J, Keck CM, Müller RH. Nanocrystals of medium soluble actives - novel concept for improved dermal delivery and production strategy. Int J Pharm. 2014;470:141-150.
- Karakucuk A, Celebi N. Investigation of formulation and process parameters of wet media milling method to develop etodolac nanosuspensions. Pharm Res. 2020;37:1-18.
- Keck CM, Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62:3-16.
- Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. Drug nanocrystals: In vivo performances. J Control Release. 2012;160:418-430.
- Zakowiecki D, Cal K, Kaminski K, Adrjanowicz K, Swinder L, Kaminska E, Garbacz G. The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations. AAPS PharmSciTech. 2015;16:922-933.
- Thombre AG, Shah JC, Sagawa K, Caldwell WB. In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations. Int J Pharm. 2012;428:8-17.
- Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56:827-840.
- Kesisoglou F, Panmai S, Wu Y. Nanosizing - Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631-644.
- Karakucuk A, Teksin ZS, Eroglu H, Celebi N. Evaluation of improved oral bioavailability of ritonavir nanosuspension. Eur J Pharm Sci. 2019;131:153-158.
- Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm. 2011;409:260-268.
- Lennernäs H. Human intestinal permeability. J Pharm Sci. 1998;87:403- 410.
- Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001;46:27-43.
- Yee S. In vitro permeability across caco-2 cells (colonic) can predict ın vivo (small intestinal) absorption in man-fact or Myth. Pharm Res. 1997;14:763-766.
- Rege BD, Yu Lawrence X, Hussain AS, Polli JE. Effect of common excipients on Caco-2 transport of low-permeability drugs. J Pharm Sci. 2001;90:1776-1786.
- Tashan E, Karakucuk A, Celebi N. Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach. J Drug Deliv Sci Technol. 2019;52:37-45.
- Tashan E, Karakucuk A, Celebi N. Development of nanocrystal ziprasidone orally disintegrating tablets: optimization by using design of experiment and in vitro evaluation. AAPS PharmSciTech. 2020;21:115. Erratum in: AAPS PharmSciTech. 2020;21:144.
- Wang H, Xiao Y, Wang H, Sang Z, Han X, Ren S, Du R, Shi X, Xie Y. Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis. Int J Pharm. 2019;566:67-76.
- Shekhawat P, Bagul M, Edwankar D, Pokharkar V. Enhanced dissolution/ caco-2 permeability, pharmacokinetic and pharmacodynamic performance of re-dispersible eprosartan mesylate nanopowder. Eur J Pharm Sci. 2019;132:72-85.
- Karakucuk A, Celebi N, Teksin ZS. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A design of experiment approach. Eur J Pharm Sci. 2016;95:111-121.
- He Y, Liu H, Xie Z, Liao Q, Lai X, Du Z. PVP and surfactant combined carrier as an effective absorption enhancer of poorly soluble astilbin in vitro and in vivo. Drug Dev Ind Pharm. 2014;40:237-243.
- Jinno JI, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 2006;111:56-64.
- Hecq J, Nollevaux G, Deleers M, Fanara D, Vranckx H, Peulen O, Dandrifosse G, Amighi K. Nifedipine nanocrystals: Pharmacokinetic evaluation in the rat and permeability studies in Caco-2/HT29-5M21 (co)-cultures. J Drug Deliv Sci Technol. 2006;16:437-442.
- Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm. 2011;77:275-282.
- Gulsun T, Borna SE, Vural I, Sahin S. Preparation and characterization of furosemide nanosuspensions. J Drug Deliv Sci Technol. 2018;45:93-100.
- Patil JS, Korachagaon A V, Shiralashetti SS, Marapur SC. Enhancing dissolution rate of ziprasidone via co-grinding technique with highly hydrophilic carriers. RGUHS J Pharm Sci. 2012;2:32-38.
- Paixão P, Gouveia LF, Morais JAG. Prediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks. Eur J Pharm Sci. 2010;41:107-117.
| APA | KARAKUCUK A, Tashan E, Ozturk N, Celebi N (2021). In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. , 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| Chicago | KARAKUCUK ALPTUG,Tashan Emine,Ozturk Naile,Celebi Nevin In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. (2021): 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| MLA | KARAKUCUK ALPTUG,Tashan Emine,Ozturk Naile,Celebi Nevin In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. , 2021, ss.111 - 115. 10.4274/tjps.galenos.2020.67366 |
| AMA | KARAKUCUK A,Tashan E,Ozturk N,Celebi N In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. . 2021; 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| Vancouver | KARAKUCUK A,Tashan E,Ozturk N,Celebi N In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. . 2021; 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| IEEE | KARAKUCUK A,Tashan E,Ozturk N,Celebi N "In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals." , ss.111 - 115, 2021. 10.4274/tjps.galenos.2020.67366 |
| ISNAD | KARAKUCUK, ALPTUG vd. "In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals". (2021), 111-115. https://doi.org/10.4274/tjps.galenos.2020.67366 |
| APA | KARAKUCUK A, Tashan E, Ozturk N, Celebi N (2021). In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. Turkish Journal of Pharmaceutical Sciences, 18(2), 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| Chicago | KARAKUCUK ALPTUG,Tashan Emine,Ozturk Naile,Celebi Nevin In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. Turkish Journal of Pharmaceutical Sciences 18, no.2 (2021): 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| MLA | KARAKUCUK ALPTUG,Tashan Emine,Ozturk Naile,Celebi Nevin In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. Turkish Journal of Pharmaceutical Sciences, vol.18, no.2, 2021, ss.111 - 115. 10.4274/tjps.galenos.2020.67366 |
| AMA | KARAKUCUK A,Tashan E,Ozturk N,Celebi N In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. Turkish Journal of Pharmaceutical Sciences. 2021; 18(2): 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| Vancouver | KARAKUCUK A,Tashan E,Ozturk N,Celebi N In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals. Turkish Journal of Pharmaceutical Sciences. 2021; 18(2): 111 - 115. 10.4274/tjps.galenos.2020.67366 |
| IEEE | KARAKUCUK A,Tashan E,Ozturk N,Celebi N "In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals." Turkish Journal of Pharmaceutical Sciences, 18, ss.111 - 115, 2021. 10.4274/tjps.galenos.2020.67366 |
| ISNAD | KARAKUCUK, ALPTUG vd. "In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals". Turkish Journal of Pharmaceutical Sciences 18/2 (2021), 111-115. https://doi.org/10.4274/tjps.galenos.2020.67366 |
